Abstract: The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Tri-Specific Binding Molecule is preferably characterized in possessing binding domains that permit it to immunospecifically bind to: (1) an epitope of a first Cancer Antigen, (2) an epitope of a second Cancer Antigen, and (3) an epitope of a molecule that is expressed on the surface of an immune system effector cell, and are thus capable of localizing an immune system effector cell to a cell that expresses a Cancer Antigen, so as to thereby facilitate the killing of such cancer cell.

Abstract: The presently disclosed subject matter provides for methods and compositions for enhancing the immune response toward cancers and pathogens. It relates to chimeric antigen receptors (CARs) that specifically target human mesothelin, and immunoresponsive cells comprising such CARs. The presently disclosed mesothelin-targeted CARs have enhanced immune-activating properties, including anti-tumor activity.

Abstract: Methods for identifying compounds that positively regulate connexin 43 hemichannels.

Abstract: CD 19×CD3 bi-specific monovalent diabodies, and particularly, CD 19×CD3 bi-specific monovalent Fc diabodies, are capable of simultaneous binding to CD 19 and CD3, and are used in the treatment of hematologic malignancies.

Abstract: Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.

Abstract: Antibodies and antigen binding fragments thereof are provided that bind to T-cell receptors (e.g., TCR?), essentially independent of T-cell epitope specificity. Methods for manipulation of T-cells and methods of treatment using such antibodies are likewise provided.

Abstract: The present invention provides antibodies directed against ICOS or a derivative thereof which neutralize ICOS engagement on Treg by inhibiting the fixation between ICOS and ICOS-L and abrogate proliferation of Treg induced by plasmacytoid dendritic cells. The present invention further provides antibodies directed against ICOS or a derivative thereof which induce IL-10 and IFN? production, induce CD4? T cells proliferation, reduce Tconv proliferation, and increase the immunosuppressive function of Treg.

Abstract: Fc domains and CH3 domains are disclosed that bind the neonatal Fc (FcRn) receptor and are at least 99% monomeric. Monomeric Fc domain molecules and CH3 domain molecules are disclosed herein that include a monomeric Fc domain or a monomeric CH3 domain and an effector molecule. In some embodiments, the monomeric Fc or monomeric CH3 domain include amino acid substitutions and/or CDR insertions in the beta strands such that they specifically bind an antigen. Methods for using these monomeric Fc domains, monomeric CH3 domains, monomeric Fc domain molecules and CH3 domain molecules are also provided.

Abstract: The present invention relates to an antibody-drug-conjugate capable of binding IGF-1R. From one aspect, the invention relates to an antibody-drug-conjugate comprising an antibody capable of binding to IGF-1R, said antibody being conjugated to at least one drug selected from derivatives of dolastatin 10 and auristatins. The invention also comprises method of treatment and the use of said antibody-drug-conjugate for the treatment of cancer.

Abstract: The invention relates to methods of treating fibrosis and inflammatory bowel disease. In one embodiment, the present invention treats gut inflammation by administering a therapeutically effective dosage of TL1A inhibitors and/or DR3 inhibitors to an individual. In another embodiment, the present invention provides a method of reversing tissue fibrosis in an individual by inhibiting TL1A-DR3 signaling function.

Abstract: Methods are provided to enhance the efficacy of antibody therapy directed to tumor cells.

Abstract: The present invention relates to a bispecific (monoclonal) antibody molecule with a first binding domain binding an antigen on CD8+ T-cells that does not naturally occur in and/or on CD8+ T-cells and a second binding domain binding to a tumor specific antigen naturally occurring on the surface of a tumor cell. The bispecific (monoclonal) antibody molecules are particularly useful in combination with transduced CD8+ T-cells comprising an antigen which does not naturally occur in and/or on CD8+ T-cells and/or a T-cell receptor.

Abstract: The invention provides modified antibodies directed against GD2 that have diminished complement fixation relative to antibody-dependent, cell-mediated cytotoxicity, which is maintained. The modified antibodies of the invention may be used in the treatment of tumors such as neuroblastoma, glioblastoma, melanoma, small-cell lung carcinoma, B-cell lymphoma, renal carcinoma, retinoblastoma, and other cancers of neuroectodermal origin.

Abstract: Disclosed herein is a hinge antibody capable of being selectively activated in a target cell or tissue to treat a condition therein. The hinge antibody includes a functional antibody, two inhibitory domains and four cleavable linkers. The functional antibody is capable of treating the condition in an activated state, and has two light chains and two heavy chains. Each inhibitory domain includes a hinge domain of an immunoglobulin and consists of two peptide arms. Each cleavable linker includes a peptide substrate cleavable by an enzyme specifically or highly expressed in the target cell or tissue, and connects one of the peptide arms of the inhibitory domains to the N-terminal of one of the light chains and heavy chains of the functional antibody. Also disclosed herein are methods for preparing and using this hinge antibody.

Abstract: The present invention provides recombinant cells that contain a genetic modification to at least one mannosyl transferase gene. As a result of the modification the cells produce a glycoprotein or glycopeptide that has an N-linked glycan profile that is simplified or more easily humanized. The glycoprotein or glycopeptide can have at least 25% fewer high mannose structures on than the glycoprotein or glycopeptide produced by a reference cell. In some embodiments the modification is a deletion or disruption of a mannosyl transferase gene, which can be in an alg3 gene. Therefore, the proteins produced are more useful for the production of therapeutic glycoproteins than those produced by species having foreign or plant-like patterns of glycosylation. The invention also provides compositions of the glycoproteins or glycopeptides and methods of making them.

Abstract: The present invention provides methods for the diagnosis and/or treatment of chronic kidney disease, immune complex-mediated GN, rheumatoid arthritis, and pulmonary fibrosis, and methods for identifying compounds for such therapeutic use.

Abstract: VISTA antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the VISTA antigen-binding molecules.

Abstract: The present invention relates to multispecific antibodies, methods for their production, pharmaceutical compositions containing said antibodies and uses thereof.

Abstract: The present disclosure is broadly concerned with the field of cancer immunotherapy. For example, the present disclosure generally related to a binding molecule comprising antibody variable light (VL) regions, variable heavy (VH) regions, constant heavy 1 (CH1) regions, and light chain constant (CL) regions that are configured to form two antigen binding Fab regions and an antigen binding Fv region so that the binding molecule binds to two different antigens.

Abstract: Provided is a composition comprising one or more protein and one or more polyalkoxy fatty compound and wherein said polyalkoxy fatty compound has structure (I) wherein R1 is a fatty group; R2 is H or a substituted or unsubstituted hydrocarbyl group; n is 0 to 5; X1 is O, S, or NH; X2 is O, S, or NH; and R3 is a polymeric group comprising polymerized units of (II) and (III)

Abstract: A binding agent of the Formula A-a?:a-S-b:b?-B:X(n), wherein A as well as B is a monovalent binder, a?:a as well as b:b? is a binding pair wherein a? and a do not interfere with the binding of b to b? and vice versa, S is a spacer of at least 1 nm in length, :X denotes a functional moiety bound either covalently or via a binding pair to at least one of a?, a, b, b? or S, (n) is an integer and at least 1, — represents a covalent bond, and the linker a-S-b has a length of 6 to 100 nm. Also disclosed are methods of producing such binding agent and certain uses thereof.

Abstract: Provided herein are purified hemicellulose compositions, sweetener compositions including purified hemicellulose compositions, as well as methods for making the same. Also provided are uses of the compositions.

Abstract: A process and equipment assembly for reacting a substituent precursor with a cyclodextrin starting material to provide a raw product comprising a cyclodextrin derivative and 1% or less of an initial amount of the substituent precursor is provided. The process of the present invention provides cyclodextrin derivatives in substantially shorter time and with fewer side products than previous processes that utilize substantially the same starting materials.

Abstract: This invention relates to a non-phthalate catalyst system for olefin polymerization. The non-phthalate catalyst system comprises (a) a solid Ziegler-Natta catalyst composition comprising a transition metal, a Group 2 metal, and one or more halogens; and one or more internal electron donor compounds; and (b) one or more external electron donor compounds.

Abstract: This invention relates to a non-phthalate catalyst system for olefin polymerization. The non-phthalate catalyst system comprises (a) a solid Ziegler-Natta catalyst composition comprising a transition metal, a Group 2 metal, and one or more halogens; and one or more internal electron donor compounds; and (b) one or more external electron donor compounds.

Abstract: Selectively hydrogenated block copolymers having semi-crystalline blocks hard blocks and copolymer soft blocks having a combination of excellent physical properties and solvent resistance have been discovered. The block copolymer comprises at least one A block of hydrogenated, polymerized 1,3-butadiene and at least one B block which is a random copolymer or a controlled distribution copolymer of conjugated diene and mono vinyl aromatic monomers in which the conjugated diene monomer units are selectively hydrogenated. Polar functionalized block embodiments of the block copolymers are also disclosed. Compositions comprising the block copolymer and articles made from the block copolymer have also been discovered. A method is disclosed which provides highly isotropic, high strength melt cast films of block copolymers.

Abstract: A low density polyethylene composition characterized by having a density in range of 0.91 to 0.94 gm/cm3, a melt index in the range of 1 to 5 g/10 minutes, a gel permeation chromatography branching index in the range of 1.2 to 1, a polydispersity index in the range of 3.5 to 7.5, a viscosity ratio in the range of 0.7 to 1, and a long chain branching frequency greater than zero at a log molecular weight (log(MW)) value in the range of 4 to 5.5. Film formed from the polyethylene compositions with favorable haze and gloss characteristics, and a process for forming such film, are also described.

Abstract: The present invention provides a method for preparing an olefin polymer which can exhibit excellent isotacticity in a high yield and thus is suitable for use in reinforcing a long fiber, and a long fiber comprising an olefin polymer produced according to the above preparation method. In the preparation method, there can be provided an olefin polymer having excellent isotacticity in a high yield can be obtained by using a supported catalyst in which a transition metal compound having a specific structure is supported on a carrier together with two kinds of cocatalysts. In particular, the supported catalyst can exhibit high activity, excellent process stability and high hydrogen reactivity, thereby providing an olefin polymer having a high flow rate with a regular and excellent morphology. Such olefin polymer exhibits high processability while having excellent mechanical properties such as a tensile strength and a flexural strength, and thus are very useful as long fiber reinforced resins.

Abstract: The invention relates to fluoropolymer filament for use in 3-D printing, and 3-D printed fluoropolymer articles having low warpage, excellent chemical resistance, excellent water resistance, flame resistance, and good mechanical integrity. Additionally, the articles of the invention have good shelf life without the need for special packaging. In particular, the invention relates to filament, 3-D printed polyvinylidene fluoride (PVDF) articles, and in particular material extrusion 3-D printing. The articles may be formed from PVDF homopolymers, copolymers, such as KYNAR® resins from Arkema, as well as polymer blends with appropriately defined low shear melt viscosity. The PVDF may optionally be a filled PVDF formulation. The physical properties of the 3-D printed articles can be maximized and warpage minimized by optimizing processing parameters.

Abstract: A method for producing a hydroxyl group-containing vinyl ether polymer according to the present invention includes: a step of radical polymerizing at least one vinyl ether selected from vinyl ether having a hydroxyl group represented by the following formula (2): wherein R7 represents an alkylene group which is straight-chained, branched or comprises an alicyclic structure, and p is 1, 2, or 3, in the presence of water as a polymerization solvent and an azo compound represented by the following formula (1) as a polymerization initiator: wherein R1 to R4 each independently represent a hydrogen atom or an alkyl group and R5 and R6 each independently represent an alkoxy group optionally having a substituent group or an alkyl amino group optionally having a substituent group.

Abstract: A method for producing a conjugated diene polymer having a high content of cis-1,4-structures with a high activity, a conjugated diene polymer, and a modified conjugated diene polymer. The catalyst for conjugated diene polymerization in the method includes: a non-metallocene type gadolinium compound (A) represented by the general formula (1); an ionic compound (B) formed of a non-coordinating anion and a cation; and an organic metal compound (C) of an element selected from the group consisting of a group 2, a group 12, and a group 13 of the periodic table.

Abstract: An object of the present invention is to provide a polyethylene-based resin composition excellent in the moldability and at the same time, excellent in the balance between impact strength and stiffness as well as in the transparency, and a molded product and a film, which are obtained by the molding of the polyethylene-based resin composition. The polyethylene-based resin composition of the present invention comprises from 41 to 99 wt % of (A) an ethylene-based polymer satisfying specific conditions and from 1 to 59 wt % of (B) an ethylene-based polymer satisfying specific conditions, wherein MFR of the composition as a whole is from 0.05 to 50 g/10 min and the density is from 0.910 to 0.960 g/cm3.

Abstract: A method of producing an ultra-high Dk material includes contacting and reacting a fluoroalkyl methacrylate; an alkyl glycol dimethacrylate; a hydrophilic agent, such as methacrylic acid; a hydroxyalkyl tris(trimethylsiloxy)silane; a hydroxyalkyl terminated polydimethylsiloxane; and styrylethyltris(trimethylsiloxy)silane. The reaction is conducted within an inert atmosphere at a pressure of at least 25 pounds per square inch (PSI) and for a period of time and at a temperature sufficient to produce the ultra-high Dk material.

Abstract: A technique for ensuring the coatability of a slurry composition and also enabling an electrochemical device to exhibit excellent high-voltage cycle characteristics is provided. A binder particle aggregate for an electrochemical device electrode comprises a plurality of binder particles that contain a polymer including 75.0 mol % or more and 99.5 mol % or less of a nitrile group-containing monomer unit, wherein a pore content ratio of the plurality of binder particles is 60% or more.

Abstract: Vanadium pyridine-imine complex having general formula (I), wherein: —R1, R2, R3, R4, R5 and R6, equal to or different from each other, represent a hydrogen atom; or are selected from linear or branched C1-C20 alkyl groups, preferably C1-C15, optionally halogenated cycloalkyl groups optionally substituted, aryl groups optionally substituted; —X1, X2 and X3, equal to or different from each other, represent a halogen atom such as, for example, chlorine, bromine, iodine, preferably chlorine; or are selected from linear or branched C1-C20 alkyl groups, preferably C1-C15, —OCOR7 groups or —OR7 groups wherein R7 is selected from linear or branched C1-C20 alkyl groups, preferably C1-C15; —Y is selected from ethers such as, for example, diethylether, tetrahydrofuran (THF), dimethoxyethane, preferably is tetrahydrofuran (THF); —n is 0 or 1. Said vanadium pyridine-imine complex having general formula (I) can be advantageously used in a catalytic system for the (co) polymerization of conjugated dienes.

Abstract: Provided are an immobilization carrier, a polyether compound used for production thereof and a method for producing the carrier. The immobilization carrier have both excellent strength and toughness while a content of a polymer forming hydrous gel is suppressed, The immobilization carrier includes a polymer having a repeated unit provided with a bisphenol group and a polyoxyalkylene group bonded to the bisphenol group. The polyoxyalkylene group is formed via copolymerization between an oxyethylene group and an oxyalkylene group with 3 or more carbon atoms and optionally having a substituent. A method for producing the immobilization carrier includes the step of preparing hydrous gel via polymerizing a polyether compound in an aqueous solution. The polyether compound includes a bisphenol group, a polyoxyalkylene group and a polymerizable group. The immobilization carrier may be applied to a microorganism immobilization carrier used for treating wastewater.

Abstract: A method for producing a composition comprising polycarbodiimide, comprising the step of the reaction of a reaction mixture which contains an aromatic polyisocyanate and a carbodiimidising catalyst, wherein, before the reaction, the aromatic polyisocyanate is treated at a temperature of ?80° C. to ?150° C. and a pressure of ?1 mbar to ?500 mbar by passing through an inert gas and/or during the reaction, the reaction mixture is treated at a temperature of ?80° C. to ?150° C. and a pressure of ?1 mbar to ?500 mbar by passing through an inert gas and wherein the content of hydrolysable chlorine in the reaction mixture is ?10 ppm.

Abstract: The present invention provides a reaction mixture comprising a polyuretdione resin, a neutralized polyol, an acid-blocked tertiary amine catalyst, and optionally, an additive package selected from the group consisting of flow control additives, and wetting agents, and solvents, wherein the acid has a pKa of greater than 4.82. Compositions made from the reaction mixture of the present invention may be catalyzed at temperatures from room temperature to 130° C. and are particularly applicable in or as coatings, adhesives, castings, composites, and sealants with good performance and extended pot-life.

Abstract: An aqueous polyurethane dispersion comprising at least one isocyanate terminated polyurethane prepolymer prepared by reacting in the presence of at least one pyrrolidone selected from the group consisting of N-n-butylpyrrolidone, N-isobutylpyrrolidone, N-sec-butylpyrrolidone and N-tert-butylpyrrolidone, a mixture (M) which comprises: at least one polyisocyanate compound (a), at least one polyol compound (b), having a molecular weight Mw of 200 to 8000 and a hydroxyl functionality of 1.5 to 6, and at least one water dispersible enhancing component having at least one hydrophilic group or potentially hydrophilic group in water.

Abstract: The invention is directed to a polymer composition comprising 60 to 85 parts by weight of a thermoplastic polyurethane; and 15 to 40 parts by weight of a polyolefin, where the parts by weight of the thermoplastic polyurethane and parts by weight of the polyolefin add up to 100 parts by weight; and further comprising 1 to 15 parts by weight of a hydrogenated block copolymer derived from a vinyl aromatic monomer and a conjugated diene monomer, based on 100 parts by weight as a total amount of the thermoplastic polyurethane and polyolefin. The invention is further directed to a molded article based on the polymer composition.

Abstract: The flame-retardant urethane resin composition contains a polyisocyanate compound, a polyol compound, a trimerization catalyst, a blowing agent, and an additive, wherein the additives include red phosphorus and a filler, and the filler has an aspect ratio of 5 to 50, an average particle diameter of 0.1 ?m or larger, but smaller than 15 ?m, and a melting point of 750° C. or higher.

Abstract: Polyurea systems comprising: (a) an amino-functional aspartic ester of the general formula (I) wherein X represents an n-valent organic radical derived from a corresponding n-functional primary amine X(NH2)n, R1 and R2 each independently represent an organic radical having no Zerevitinov active hydrogens and n represents an integer of at least 2; and (b) an isocyanate functional prepolymer having a residual monomer content of less than 1% by weight, the prepolymer prepared by reacting: (b1) an aliphatic isocyante; and (b2) a polyol component having a number average molecular weight of ?400 g/mol and an average OH functionality of 2 to 6, wherein the polyol component comprises one or more constituents selected from the group consisting of polyester polyols, polyester-polyether polyols and mixtures thereof; processes for making the same; postoperative adhesions barriers prepared therewith and dispensing systems for such polyurea systems.

Abstract: The invention relates to a new polyurethane system which can be advantageously used for the production of large structural components made of fiber composite materials, to the use of said polyurethane reaction system for the production of fiber-reinforced structural components, and to the fiber-reinforced structural components produced using the new polyurethane system.

Abstract: A foaming thermoplastic polyurethane resin is a reaction product of a polyisocyanate component containing a bis(isocyanatomethyl)cyclohexane and a polyol component. In a peak of chromatogram obtained by measurement of the foaming thermoplastic polyurethane resin with gel permeation chromatography, the area of a high molecular weight component having a weight average molecular weight of 400,000 or more with respect to the total area of the peak is 25% or more and 60% or less.

Abstract: A method of improving the adhesion of metathesis compositions, such as ring-opening metathesis polymerization (ROMP) compositions, to a substrate is disclosed, in which an adhesion promoter is added to a polymerizable resin composition in order to improve the adhesion of the polymerizing resin to a substrate material. The addition of the adhesion promoter has been found to provide beneficial improvements in the adhesion of metathesis, especially ROMP, compositions to substrates, particularly glass surfaces, leading to improved characteristics in ROMP materials formed therefrom. The adhesion promoter generally comprises a functionalized silane compound and a peroxide compound. A ROMP composition is further disclosed comprising a cyclic olefin, a ROMP metathesis catalyst, and the adhesion promoter.

Abstract: The present invention relates to a thermoplastic copolymer, block copolymer, and statistical copolymer comprising plural acrylated polyol monomeric units having different degrees of acrylation of hydroxyl groups. The acrylated polyol monomeric units have an average degree of acrylation greater than 1 and less than the number of the hydroxyl groups of the polyol. The present invention also relates to a method of making the thermoplastic copolymer, block copolymer, and statistical copolymer, and using them in various applications, such as asphalt rubber modifiers, adhesives, or an additive in a fracking fluid for oil fracking.

Abstract: A polymer resin compound, a photosensitive resin composition for a black bank comprising the polymer resin compound, and a method for manufacturing a black bank. The method comprises coating the photosensitive resin composition on a substrate to form a photosensitive resin film; exposing and developing the photosensitive resin film to pattern the coated photosensitive resin film; and curing the patterned photosensitive resin film.

Abstract: The disclosure concerns healable polycarbonate resins comprising at least about 5 mol % of disulfide units, articles comprising the healable polycarbonate resin, and methods of activating the healable polycarbonate resin by exposing the healable polycarbonate resin to heat or radiation.

Abstract: The present invention relates to an organic zinc catalyst which exhibits more improved catalytic activity than conventional organic zinc catalysts during a polymerization process for the preparation of a polyalkylene carbonate resin and is capable of preventing an aggregation phenomenon during a reaction, a method for preparing the same, and a method for preparing a polyalkylene carbonate resin using the organic zinc catalyst. The method for preparing an organic zinc catalyst includes the step of reacting a zinc precursor with a dicarboxylic acid in the presence of a polyether derivative to form a zinc dicarboxylate-based catalyst.

Abstract: A hydrophilic polymer derivative having a benzylidene acetal linker whose hydrolysis rate at the pH of a weakly acidic environment in the living body can be accurately controlled. A hydrophilic polymer derivative having a benzylidene acetal linker, which is represented by the following formula (1): wherein R1 is a hydrogen atom or a hydrocarbon group; R2, R3, R4, R5, and R6 are each independently a hydrogen atom or a substituent and at least one of R3, R4, and R5 is an electron-withdrawing substituent or at least one of R2 and R6 represents a substituent; X1 is a chemically reactive functional group; P is a hydrophilic polymer; w is an integer of 1 to 8; and Z1 and Z2 are an independently selected divalent spacer.